UpHealth, Inc. (UPHL)
OTCMKTS
· Delayed Price · Currency is USD
0.0004
+0.0001 (33.33%)
Dec 24, 2024, 4:00 PM EST
UpHealth Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Revenue | 105.31 | 130 | 158.8 | 123.8 | 5.4 |
Revenue Growth (YoY) | -28.61% | -18.14% | 28.28% | 2194.20% | - |
Cost of Revenue | 48.21 | 60.4 | 88.65 | 83.98 | 1.18 |
Gross Profit | 57.1 | 69.6 | 70.16 | 39.81 | 4.21 |
Selling, General & Admin | 41.18 | 50.17 | 64.71 | 62.92 | 4.95 |
Research & Development | 3.35 | 4.37 | 7.89 | 7.64 | 0.87 |
Operating Expenses | 54.3 | 64.73 | 95.2 | 84.66 | 6.14 |
Operating Income | 2.81 | 4.86 | -25.04 | -44.85 | -1.93 |
Interest Expense | -26.97 | -28.2 | -26.5 | -19.52 | -0.13 |
Earnings From Equity Investments | - | - | - | 0.08 | -0.08 |
Other Non Operating Income (Expenses) | 4.55 | 1.07 | 7.89 | 55.93 | 0 |
EBT Excluding Unusual Items | -19.61 | -22.27 | -43.65 | -8.35 | -2.14 |
Merger & Restructuring Charges | -41.25 | -44.48 | -20.11 | -36.29 | - |
Impairment of Goodwill | -42.42 | -42.92 | -94.64 | -297.93 | - |
Gain (Loss) on Sale of Assets | 59.07 | 59.07 | -37.71 | - | - |
Asset Writedown | -7.04 | -7.03 | -21.6 | - | - |
Other Unusual Items | - | - | -14.61 | -0.76 | - |
Pretax Income | -51.26 | -57.63 | -232.32 | -343.33 | -2.14 |
Income Tax Expense | 3.3 | -1.22 | -9.38 | -2.44 | 0.05 |
Earnings From Continuing Operations | -54.56 | -56.42 | -222.94 | -340.9 | -2.19 |
Minority Interest in Earnings | -0.98 | -1.42 | -0.07 | -0.13 | - |
Net Income | -24.34 | -57.84 | -223 | -341.02 | -2.19 |
Net Income to Common | -24.34 | -57.84 | -223 | -341.02 | -2.19 |
Shares Outstanding (Basic) | 18 | 18 | 15 | 11 | 5 |
Shares Outstanding (Diluted) | 18 | 18 | 15 | 11 | 5 |
Shares Change (YoY) | 22.96% | 20.58% | 37.34% | 104.46% | - |
EPS (Basic) | -1.32 | -3.26 | -15.17 | -31.86 | -0.42 |
EPS (Diluted) | -1.32 | -3.26 | -15.17 | -31.86 | -0.42 |
Free Cash Flow | -23.38 | -21.64 | -29.28 | -66.54 | -1.14 |
Free Cash Flow Per Share | -1.27 | -1.22 | -1.99 | -6.22 | -0.22 |
Gross Margin | 54.22% | 53.54% | 44.18% | 32.16% | 78.08% |
Operating Margin | 2.66% | 3.74% | -15.77% | -36.23% | -35.69% |
Profit Margin | -23.11% | -44.49% | -140.43% | -275.47% | -40.51% |
Free Cash Flow Margin | -22.20% | -16.64% | -18.44% | -53.75% | -21.11% |
EBITDA | 13.35 | 15.82 | -3.24 | -28.08 | -1.61 |
EBITDA Margin | 12.68% | 12.17% | -2.04% | -22.68% | -29.74% |
D&A For EBITDA | 10.55 | 10.95 | 21.8 | 16.77 | 0.32 |
EBIT | 2.81 | 4.86 | -25.04 | -44.85 | -1.93 |
EBIT Margin | 2.66% | 3.74% | -15.77% | -36.23% | -35.69% |
Revenue as Reported | 105.31 | 130 | 158.8 | 123.8 | 5.4 |
Advertising Expenses | - | 1.3 | 2.9 | 3.2 | 0.02 |
Source: S&P Capital IQ. Standard template. Financial Sources.